Disc Medicine Statistics

Total Valuation

Disc Medicine has a market cap or net worth of $1.61 billion. The enterprise value is $950.28 million.

Market Cap	1.61B
Enterprise Value	950.28M

Important Dates

The last earnings date was Wednesday, May 7, 2025, before market open.

Earnings Date	May 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Disc Medicine has 34.63 million shares outstanding. The number of shares has increased by 25.04% in one year.

Current Share Class	34.63M
Shares Outstanding	34.63M
Shares Change (YoY)	+25.04%
Shares Change (QoQ)	+11.10%
Owned by Insiders (%)	0.50%
Owned by Institutions (%)	65.90%
Float	26.64M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.44
P/TBV Ratio	2.44
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 37.65, with a Debt / Equity ratio of 0.05.

Current Ratio	37.65
Quick Ratio	37.07
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-94.08

Financial Efficiency

Return on equity (ROE) is -23.34% and return on invested capital (ROIC) is -16.75%.

Return on Equity (ROE)	-23.34%
Return on Assets (ROA)	-16.24%
Return on Invested Capital (ROIC)	-16.75%
Return on Capital Employed (ROCE)	-20.01%
Revenue Per Employee	n/a
Profits Per Employee	-$1.39M
Employee Count	84
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Disc Medicine has paid $469,000 in taxes.

Income Tax	469,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +53.52% in the last 52 weeks. The beta is 2.78, so Disc Medicine's price volatility has been higher than the market average.

Beta (5Y)	2.78
52-Week Price Change	+53.52%
50-Day Moving Average	47.75
200-Day Moving Average	52.62
Relative Strength Index (RSI)	52.06
Average Volume (20 Days)	399,148

Short Selling Information

The latest short interest is 3.21 million, so 9.28% of the outstanding shares have been sold short.

Short Interest	3.21M
Short Previous Month	2.73M
Short % of Shares Out	9.28%
Short % of Float	12.06%
Short Ratio (days to cover)	5.69

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-138.20M
Pretax Income	-90.89M
Net Income	-116.49M
EBITDA	-138.05M
EBIT	-138.20M
Earnings Per Share (EPS)	-$3.92

Full Income Statement

Balance Sheet

The company has $694.66 million in cash and $30.64 million in debt, giving a net cash position of $664.02 million or $19.17 per share.

Cash & Cash Equivalents	694.66M
Total Debt	30.64M
Net Cash	664.02M
Net Cash Per Share	$19.17
Equity (Book Value)	660.36M
Book Value Per Share	19.10
Working Capital	686.86M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$101.70 million and capital expenditures -$1.29 million, giving a free cash flow of -$102.99 million.

Operating Cash Flow	-101.70M
Capital Expenditures	-1.29M
Free Cash Flow	-102.99M
FCF Per Share	-$2.97

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Disc Medicine does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-25.04%
Shareholder Yield	-25.04%
Earnings Yield	-7.22%
FCF Yield	-6.38%

Dividend Details

Analyst Forecast

The average price target for Disc Medicine is $93.89, which is 101.27% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$93.89
Price Target Difference	101.27%
Analyst Consensus	Strong Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2